

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 6.26516881 |
| 2 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 6.26516881 |
| 3 | purine nucleotide salvage (GO:0032261) | 5.77945414 |
| 4 | nucleotide salvage (GO:0043173) | 5.35666459 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 5.32695251 |
| 6 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.82026405 |
| 7 | galactose catabolic process (GO:0019388) | 4.71825308 |
| 8 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.28990469 |
| 9 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.99057535 |
| 10 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.98752570 |
| 11 | galactose metabolic process (GO:0006012) | 3.89412577 |
| 12 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.87914004 |
| 13 | regulation of plasminogen activation (GO:0010755) | 3.75529905 |
| 14 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.66448601 |
| 15 | deoxyribonucleotide catabolic process (GO:0009264) | 3.62362946 |
| 16 | serine family amino acid biosynthetic process (GO:0009070) | 3.57817162 |
| 17 | homocysteine metabolic process (GO:0050667) | 3.57634965 |
| 18 | protein maturation by protein folding (GO:0022417) | 3.55090856 |
| 19 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.53941071 |
| 20 | deoxyribose phosphate catabolic process (GO:0046386) | 3.52763774 |
| 21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.50363456 |
| 22 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.44408932 |
| 23 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.39482825 |
| 24 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.35624433 |
| 25 | NADH dehydrogenase complex assembly (GO:0010257) | 3.35624433 |
| 26 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.35624433 |
| 27 | adenine nucleotide transport (GO:0051503) | 3.33688227 |
| 28 | purine ribonucleotide transport (GO:0015868) | 3.33643855 |
| 29 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.32286338 |
| 30 | ATP synthesis coupled proton transport (GO:0015986) | 3.32286338 |
| 31 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.28141779 |
| 32 | purine-containing compound salvage (GO:0043101) | 3.26677875 |
| 33 | viral transcription (GO:0019083) | 3.23767595 |
| 34 | white fat cell differentiation (GO:0050872) | 3.20809926 |
| 35 | glycoside metabolic process (GO:0016137) | 3.17911547 |
| 36 | nucleoside transport (GO:0015858) | 3.16974510 |
| 37 | negative regulation of epidermis development (GO:0045683) | 3.16715905 |
| 38 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.15734109 |
| 39 | polyamine metabolic process (GO:0006595) | 3.13549962 |
| 40 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.12445266 |
| 41 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.12290354 |
| 42 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.12290354 |
| 43 | cysteine metabolic process (GO:0006534) | 3.11654415 |
| 44 | cellular metabolic compound salvage (GO:0043094) | 3.09479262 |
| 45 | protein complex biogenesis (GO:0070271) | 3.09418678 |
| 46 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.09196259 |
| 47 | GTP biosynthetic process (GO:0006183) | 3.09187823 |
| 48 | nucleoside transmembrane transport (GO:1901642) | 3.06469851 |
| 49 | L-serine metabolic process (GO:0006563) | 3.04102184 |
| 50 | base-excision repair, AP site formation (GO:0006285) | 3.03053161 |
| 51 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.00416335 |
| 52 | mannosylation (GO:0097502) | 2.96292142 |
| 53 | translational termination (GO:0006415) | 2.92578609 |
| 54 | protein localization to endoplasmic reticulum (GO:0070972) | 2.92006269 |
| 55 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.91919343 |
| 56 | negative regulation of Notch signaling pathway (GO:0045746) | 2.91627070 |
| 57 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.90497789 |
| 58 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.89516188 |
| 59 | GDP-mannose metabolic process (GO:0019673) | 2.87593366 |
| 60 | protein targeting to ER (GO:0045047) | 2.85907229 |
| 61 | cotranslational protein targeting to membrane (GO:0006613) | 2.85520567 |
| 62 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.84537061 |
| 63 | nucleoside salvage (GO:0043174) | 2.79879285 |
| 64 | virion assembly (GO:0019068) | 2.79187340 |
| 65 | rRNA modification (GO:0000154) | 2.78567704 |
| 66 | pentose metabolic process (GO:0019321) | 2.78503464 |
| 67 | viral protein processing (GO:0019082) | 2.78208009 |
| 68 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.78174816 |
| 69 | peptidyl-histidine modification (GO:0018202) | 2.77691247 |
| 70 | desmosome organization (GO:0002934) | 2.77077063 |
| 71 | electron transport chain (GO:0022900) | 2.76485858 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.76175256 |
| 73 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.74014046 |
| 74 | respiratory electron transport chain (GO:0022904) | 2.72133850 |
| 75 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.72058103 |
| 76 | translational elongation (GO:0006414) | 2.71744577 |
| 77 | UTP biosynthetic process (GO:0006228) | 2.67142333 |
| 78 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.66725843 |
| 79 | platelet dense granule organization (GO:0060155) | 2.66270850 |
| 80 | rRNA methylation (GO:0031167) | 2.63981016 |
| 81 | adenosine metabolic process (GO:0046085) | 2.62713981 |
| 82 | amyloid precursor protein catabolic process (GO:0042987) | 2.62325365 |
| 83 | positive regulation of translational initiation (GO:0045948) | 2.62242837 |
| 84 | heme biosynthetic process (GO:0006783) | 2.61993212 |
| 85 | 4-hydroxyproline metabolic process (GO:0019471) | 2.61020854 |
| 86 | glycosphingolipid catabolic process (GO:0046479) | 2.59994123 |
| 87 | carbohydrate derivative transport (GO:1901264) | 2.59401788 |
| 88 | deoxyribose phosphate metabolic process (GO:0019692) | 2.59104465 |
| 89 | lipopolysaccharide metabolic process (GO:0008653) | 2.58892558 |
| 90 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.58472700 |
| 91 | purine nucleotide transport (GO:0015865) | 2.58163215 |
| 92 | protein retention in ER lumen (GO:0006621) | 2.56557604 |
| 93 | ubiquinone biosynthetic process (GO:0006744) | 2.56221025 |
| 94 | sequestering of actin monomers (GO:0042989) | 2.52643295 |
| 95 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.52395829 |
| 96 | oxidative phosphorylation (GO:0006119) | 2.51968676 |
| 97 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.51807950 |
| 98 | viral life cycle (GO:0019058) | 2.51362025 |
| 99 | polyamine biosynthetic process (GO:0006596) | 2.50221004 |
| 100 | negative regulation of Ras GTPase activity (GO:0034261) | 2.49605294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.21786289 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.84977276 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.95229392 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.92420486 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.89584241 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79119509 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.59572088 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53622430 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.25510679 |
| 10 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.25441659 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.23219081 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.16261165 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14952058 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.08241675 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.07875116 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.02835533 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.01504363 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.97228099 |
| 19 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.90406949 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84977528 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81933156 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79296587 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78705915 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.78109690 |
| 25 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.75247798 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.73724020 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.73164746 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.72729741 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68728467 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.68466313 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66970295 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.64396584 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60380374 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57485806 |
| 35 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54826306 |
| 36 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51925936 |
| 37 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.51167119 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.49139266 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47440904 |
| 40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46763415 |
| 41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.46045425 |
| 42 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.43557135 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.43469158 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42223217 |
| 45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41842902 |
| 46 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38193845 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35366682 |
| 48 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34884512 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34386065 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32130859 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32022934 |
| 52 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.31706183 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29154798 |
| 54 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.28485507 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28175829 |
| 56 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24655554 |
| 57 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23747521 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23603933 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23450411 |
| 60 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21957722 |
| 61 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21840016 |
| 62 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21473468 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19745053 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19183181 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18829084 |
| 66 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18591218 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18479968 |
| 68 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18444998 |
| 69 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.18181777 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18003935 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17370581 |
| 72 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.17147520 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.16787376 |
| 74 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.16574241 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11724963 |
| 76 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11578919 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11213470 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08681604 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08321144 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08015664 |
| 81 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06332179 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04839690 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.04577043 |
| 84 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04496937 |
| 85 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01858822 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01810849 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98886123 |
| 88 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98779697 |
| 89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97573931 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97425298 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97013646 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97004928 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95311256 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93427049 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93340932 |
| 96 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93273264 |
| 97 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92735888 |
| 98 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92327614 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.91994582 |
| 100 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.91992695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 4.03011720 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.92348075 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.52809328 |
| 4 | MP0008789_abnormal_olfactory_epithelium | 3.37128813 |
| 5 | MP0005670_abnormal_white_adipose | 3.21378579 |
| 6 | MP0005394_taste/olfaction_phenotype | 2.97977805 |
| 7 | MP0005499_abnormal_olfactory_system | 2.97977805 |
| 8 | MP0010030_abnormal_orbit_morphology | 2.92463839 |
| 9 | MP0005360_urolithiasis | 2.83361378 |
| 10 | MP0001661_extended_life_span | 2.61929195 |
| 11 | MP0002234_abnormal_pharynx_morphology | 2.50749509 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.44717251 |
| 13 | MP0003186_abnormal_redox_activity | 2.30973421 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.21507878 |
| 15 | MP0000003_abnormal_adipose_tissue | 2.21094034 |
| 16 | MP0008995_early_reproductive_senescence | 2.13796456 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.06546582 |
| 18 | MP0001764_abnormal_homeostasis | 1.93931515 |
| 19 | MP0002938_white_spotting | 1.88130053 |
| 20 | MP0000678_abnormal_parathyroid_gland | 1.77923093 |
| 21 | MP0004233_abnormal_muscle_weight | 1.71649761 |
| 22 | MP0000372_irregular_coat_pigmentation | 1.70068376 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.65565681 |
| 24 | MP0001664_abnormal_digestion | 1.58279868 |
| 25 | MP0004147_increased_porphyrin_level | 1.54405431 |
| 26 | MP0003786_premature_aging | 1.51753877 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.50505248 |
| 28 | MP0003011_delayed_dark_adaptation | 1.48529289 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.46933838 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.46383526 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.45864282 |
| 32 | MP0000343_altered_response_to | 1.43963731 |
| 33 | MP0003136_yellow_coat_color | 1.37469876 |
| 34 | MP0000490_abnormal_crypts_of | 1.36148794 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.34922774 |
| 36 | MP0009697_abnormal_copulation | 1.34287128 |
| 37 | MP0009785_altered_susceptibility_to | 1.20982974 |
| 38 | MP0002132_abnormal_respiratory_system | 1.20262917 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.18284799 |
| 40 | MP0005381_digestive/alimentary_phenotyp | 1.17796795 |
| 41 | MP0001663_abnormal_digestive_system | 1.17224723 |
| 42 | MP0005332_abnormal_amino_acid | 1.17139853 |
| 43 | MP0000538_abnormal_urinary_bladder | 1.12881065 |
| 44 | MP0009053_abnormal_anal_canal | 1.12063029 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.11684848 |
| 46 | MP0003938_abnormal_ear_development | 1.10200234 |
| 47 | MP0000467_abnormal_esophagus_morphology | 1.07396415 |
| 48 | MP0003724_increased_susceptibility_to | 1.05440429 |
| 49 | MP0001542_abnormal_bone_strength | 1.05349042 |
| 50 | MP0009840_abnormal_foam_cell | 1.04665180 |
| 51 | MP0000462_abnormal_digestive_system | 1.01386820 |
| 52 | MP0000383_abnormal_hair_follicle | 0.99275699 |
| 53 | MP0005165_increased_susceptibility_to | 0.98090780 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 0.97534371 |
| 55 | MP0000049_abnormal_middle_ear | 0.97298665 |
| 56 | MP0005375_adipose_tissue_phenotype | 0.97186063 |
| 57 | MP0000681_abnormal_thyroid_gland | 0.97141600 |
| 58 | MP0002295_abnormal_pulmonary_circulatio | 0.97037216 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 0.96004387 |
| 60 | MP0002095_abnormal_skin_pigmentation | 0.95731586 |
| 61 | MP0003183_abnormal_peptide_metabolism | 0.93418425 |
| 62 | MP0005083_abnormal_biliary_tract | 0.93061487 |
| 63 | MP0001905_abnormal_dopamine_level | 0.90301126 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 0.89826496 |
| 65 | MP0001529_abnormal_vocalization | 0.89450997 |
| 66 | MP0000566_synostosis | 0.87973596 |
| 67 | MP0002098_abnormal_vibrissa_morphology | 0.84254244 |
| 68 | MP0000026_abnormal_inner_ear | 0.81904576 |
| 69 | MP0008961_abnormal_basal_metabolism | 0.80964232 |
| 70 | MP0005666_abnormal_adipose_tissue | 0.78933741 |
| 71 | MP0000762_abnormal_tongue_morphology | 0.78630604 |
| 72 | MP0000516_abnormal_urinary_system | 0.78277988 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 0.78277988 |
| 74 | MP0009643_abnormal_urine_homeostasis | 0.77427719 |
| 75 | MP0002282_abnormal_trachea_morphology | 0.77141129 |
| 76 | MP0000470_abnormal_stomach_morphology | 0.77122283 |
| 77 | MP0003942_abnormal_urinary_system | 0.75168556 |
| 78 | MP0000858_altered_metastatic_potential | 0.75164245 |
| 79 | MP0008469_abnormal_protein_level | 0.74098372 |
| 80 | MP0000534_abnormal_ureter_morphology | 0.74084391 |
| 81 | MP0005193_abnormal_anterior_eye | 0.73902654 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.72657619 |
| 83 | MP0001756_abnormal_urination | 0.72268917 |
| 84 | MP0009764_decreased_sensitivity_to | 0.71751911 |
| 85 | MP0004858_abnormal_nervous_system | 0.71058551 |
| 86 | MP0002736_abnormal_nociception_after | 0.70913479 |
| 87 | MP0002932_abnormal_joint_morphology | 0.69344154 |
| 88 | MP0000358_abnormal_cell_content/ | 0.69203553 |
| 89 | MP0009278_abnormal_bone_marrow | 0.68425472 |
| 90 | MP0008004_abnormal_stomach_pH | 0.68279269 |
| 91 | MP0001727_abnormal_embryo_implantation | 0.67370587 |
| 92 | MP0002909_abnormal_adrenal_gland | 0.65138190 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.64864723 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.64854360 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.62997229 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62579296 |
| 97 | MP0005451_abnormal_body_composition | 0.60560250 |
| 98 | MP0001243_abnormal_dermal_layer | 0.59893266 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.59877334 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.59310999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of alanine metabolism (HP:0010916) | 4.20128501 |
| 2 | Hyperalaninemia (HP:0003348) | 4.20128501 |
| 3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.20128501 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 3.76181546 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.76181546 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.76181546 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.45060578 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.34675115 |
| 9 | Microretrognathia (HP:0000308) | 3.28886269 |
| 10 | Prolonged neonatal jaundice (HP:0006579) | 3.11793437 |
| 11 | Hypoplastic left heart (HP:0004383) | 3.06639751 |
| 12 | Hepatic necrosis (HP:0002605) | 3.03263881 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.02160753 |
| 14 | Median cleft lip (HP:0000161) | 2.97444754 |
| 15 | Mitochondrial inheritance (HP:0001427) | 2.88884808 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.88552398 |
| 17 | Spontaneous hematomas (HP:0007420) | 2.86528777 |
| 18 | Generalized aminoaciduria (HP:0002909) | 2.85395896 |
| 19 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.83075467 |
| 20 | Acute encephalopathy (HP:0006846) | 2.82601988 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.77624680 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.77624680 |
| 23 | Hypertensive crisis (HP:0100735) | 2.75140229 |
| 24 | Beaking of vertebral bodies (HP:0004568) | 2.72824618 |
| 25 | Constricted visual fields (HP:0001133) | 2.66680507 |
| 26 | Lactic acidosis (HP:0003128) | 2.59552024 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 2.53120828 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.51141296 |
| 29 | Type I transferrin isoform profile (HP:0003642) | 2.45916466 |
| 30 | Short nail (HP:0001799) | 2.43772942 |
| 31 | Cortical visual impairment (HP:0100704) | 2.41387612 |
| 32 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.40352166 |
| 33 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.40352166 |
| 34 | Abnormal protein glycosylation (HP:0012346) | 2.40352166 |
| 35 | Abnormal glycosylation (HP:0012345) | 2.40352166 |
| 36 | White forelock (HP:0002211) | 2.37801838 |
| 37 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.37764648 |
| 38 | Thoracic kyphosis (HP:0002942) | 2.36710806 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.33133980 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.30511357 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.30384486 |
| 42 | Increased CSF lactate (HP:0002490) | 2.30358526 |
| 43 | Myopathic facies (HP:0002058) | 2.29812707 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.29486350 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.27292780 |
| 46 | Oligomenorrhea (HP:0000876) | 2.26539573 |
| 47 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.25961071 |
| 48 | Increased serum lactate (HP:0002151) | 2.24517391 |
| 49 | Patchy hypopigmentation of hair (HP:0011365) | 2.22263616 |
| 50 | Progressive macrocephaly (HP:0004481) | 2.21621610 |
| 51 | Esophageal varix (HP:0002040) | 2.20912314 |
| 52 | Hypoplastic heart (HP:0001961) | 2.19603263 |
| 53 | Hyperammonemia (HP:0001987) | 2.17002742 |
| 54 | Exercise intolerance (HP:0003546) | 2.14166234 |
| 55 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13343050 |
| 56 | Sclerocornea (HP:0000647) | 2.12698821 |
| 57 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.12640342 |
| 58 | Biconcave vertebral bodies (HP:0004586) | 2.11750248 |
| 59 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.11425532 |
| 60 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.11425532 |
| 61 | Single umbilical artery (HP:0001195) | 2.11425532 |
| 62 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.09938417 |
| 63 | Renal Fanconi syndrome (HP:0001994) | 2.09347926 |
| 64 | Down-sloping shoulders (HP:0200021) | 2.08890634 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.06798461 |
| 66 | Petechiae (HP:0000967) | 2.02197768 |
| 67 | Maternal diabetes (HP:0009800) | 2.02125202 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.01748884 |
| 69 | Respiratory failure (HP:0002878) | 2.01568245 |
| 70 | Congenital sensorineural hearing impairment (HP:0008527) | 2.01405165 |
| 71 | Pancreatic fibrosis (HP:0100732) | 2.00805190 |
| 72 | Cerebral edema (HP:0002181) | 1.97992317 |
| 73 | Abnormal number of erythroid precursors (HP:0012131) | 1.97303827 |
| 74 | Abnormality of the tricuspid valve (HP:0001702) | 1.96800773 |
| 75 | Congenital primary aphakia (HP:0007707) | 1.96757484 |
| 76 | Redundant skin (HP:0001582) | 1.93351847 |
| 77 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.92227332 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 1.91849027 |
| 79 | Double outlet right ventricle (HP:0001719) | 1.91848859 |
| 80 | Congenital malformation of the right heart (HP:0011723) | 1.91848859 |
| 81 | Nonimmune hydrops fetalis (HP:0001790) | 1.86593381 |
| 82 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.83868072 |
| 83 | Conjunctival telangiectasia (HP:0000524) | 1.82687933 |
| 84 | Death in infancy (HP:0001522) | 1.81561353 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 1.80516486 |
| 86 | Broad distal phalanx of finger (HP:0009836) | 1.79033933 |
| 87 | Abnormality of the umbilical cord (HP:0010881) | 1.78292542 |
| 88 | Gait imbalance (HP:0002141) | 1.75973994 |
| 89 | Concave nail (HP:0001598) | 1.74521109 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 1.74262114 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74262114 |
| 92 | Reticulocytopenia (HP:0001896) | 1.73519415 |
| 93 | Dysostosis multiplex (HP:0000943) | 1.73094349 |
| 94 | Medial flaring of the eyebrow (HP:0010747) | 1.69409672 |
| 95 | Increased serum ferritin (HP:0003281) | 1.68428386 |
| 96 | Nausea (HP:0002018) | 1.68167317 |
| 97 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.67675235 |
| 98 | CNS demyelination (HP:0007305) | 1.67195697 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 1.66948742 |
| 100 | Cholecystitis (HP:0001082) | 1.66948742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.85632475 |
| 2 | NME2 | 4.21700910 |
| 3 | BCKDK | 3.99565590 |
| 4 | PIM2 | 3.45057362 |
| 5 | ERN1 | 3.09574742 |
| 6 | STK16 | 2.90479142 |
| 7 | ARAF | 2.86074306 |
| 8 | TESK1 | 2.69270526 |
| 9 | MAP2K3 | 2.65793559 |
| 10 | MAP3K3 | 2.47013913 |
| 11 | SMG1 | 2.32801572 |
| 12 | TESK2 | 2.17138022 |
| 13 | SCYL2 | 2.03541452 |
| 14 | NEK1 | 1.94707772 |
| 15 | MAP3K11 | 1.87710116 |
| 16 | IRAK3 | 1.87103115 |
| 17 | NUAK1 | 1.81952539 |
| 18 | EPHA2 | 1.55188682 |
| 19 | EPHB2 | 1.51112538 |
| 20 | LIMK1 | 1.42847600 |
| 21 | TBK1 | 1.41639104 |
| 22 | STK4 | 1.40458198 |
| 23 | CDK9 | 1.40209852 |
| 24 | TRIB3 | 1.36939130 |
| 25 | PBK | 1.34254420 |
| 26 | ABL2 | 1.25881618 |
| 27 | BUB1 | 1.20906895 |
| 28 | TYK2 | 1.17631725 |
| 29 | VRK1 | 1.15797458 |
| 30 | DAPK3 | 1.11717682 |
| 31 | LRRK2 | 1.10801172 |
| 32 | CSNK1G3 | 1.07252384 |
| 33 | DAPK1 | 1.04698113 |
| 34 | PRKD3 | 1.03673115 |
| 35 | PAK4 | 1.03530858 |
| 36 | DYRK3 | 1.03013000 |
| 37 | AURKA | 0.99693979 |
| 38 | CCNB1 | 0.99128821 |
| 39 | TLK1 | 0.96534083 |
| 40 | IRAK2 | 0.95924813 |
| 41 | KDR | 0.95141498 |
| 42 | TAF1 | 0.92435842 |
| 43 | NME1 | 0.91075200 |
| 44 | IKBKB | 0.86891829 |
| 45 | SIK1 | 0.86097647 |
| 46 | PRKCI | 0.84069097 |
| 47 | RPS6KB2 | 0.80002404 |
| 48 | TRIM28 | 0.79044654 |
| 49 | CAMK2G | 0.76667931 |
| 50 | MAP3K1 | 0.73831225 |
| 51 | IKBKE | 0.70067508 |
| 52 | LMTK2 | 0.70012323 |
| 53 | PKN2 | 0.68694877 |
| 54 | GRK6 | 0.66441582 |
| 55 | DYRK2 | 0.65096038 |
| 56 | JAK3 | 0.64766163 |
| 57 | ZAK | 0.62849234 |
| 58 | ADRBK2 | 0.62211427 |
| 59 | RPS6KA4 | 0.58401092 |
| 60 | CHUK | 0.57806214 |
| 61 | MAP3K8 | 0.56409958 |
| 62 | TAOK2 | 0.55134656 |
| 63 | ADRBK1 | 0.54509891 |
| 64 | MAP2K6 | 0.53630653 |
| 65 | BRAF | 0.53093333 |
| 66 | PRKG2 | 0.53055573 |
| 67 | CSNK1G1 | 0.52488872 |
| 68 | CSNK1G2 | 0.52085195 |
| 69 | CDK7 | 0.51568375 |
| 70 | CDK8 | 0.50038210 |
| 71 | FGR | 0.49834271 |
| 72 | PTK6 | 0.49309690 |
| 73 | AURKB | 0.49131779 |
| 74 | MET | 0.49000891 |
| 75 | DYRK1B | 0.47944330 |
| 76 | MAP3K6 | 0.47289936 |
| 77 | ILK | 0.46989139 |
| 78 | RAF1 | 0.46338866 |
| 79 | PAK1 | 0.45981630 |
| 80 | MAP4K1 | 0.43158580 |
| 81 | MAPKAPK2 | 0.42999389 |
| 82 | CSNK1A1L | 0.39859321 |
| 83 | AKT2 | 0.38671434 |
| 84 | RPS6KA5 | 0.37686477 |
| 85 | CSF1R | 0.37052482 |
| 86 | PIM1 | 0.36711253 |
| 87 | BMPR1B | 0.35607874 |
| 88 | PRKD1 | 0.35198285 |
| 89 | CAMK2D | 0.34468601 |
| 90 | CAMKK2 | 0.33546502 |
| 91 | SGK223 | 0.32515405 |
| 92 | SGK494 | 0.32515405 |
| 93 | CAMK2B | 0.32269376 |
| 94 | IRAK4 | 0.32256826 |
| 95 | IRAK1 | 0.30836059 |
| 96 | PRKCD | 0.30625935 |
| 97 | CSNK1A1 | 0.30552150 |
| 98 | BMX | 0.29895473 |
| 99 | GRK5 | 0.29236058 |
| 100 | CSNK2A1 | 0.27955897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 3.92773178 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.37131058 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.36082063 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.10817245 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.10165358 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.88081508 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.78692224 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.63294295 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.46176118 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.45518851 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.31481733 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.03475418 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.94227537 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90869396 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84893654 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.80488030 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.77462828 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.68028078 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66862254 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.65632235 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.64175934 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.61552414 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.60600344 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59934549 |
| 25 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59058156 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.58438929 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.53830711 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.52997870 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47078022 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.42930286 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40965311 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.40846949 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.39071479 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.37105123 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30496885 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.29926431 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27752850 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26265460 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24576221 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24568903 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23936095 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23543687 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19765387 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14142881 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02718946 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02127097 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00608353 |
| 48 | Metabolic pathways_Homo sapiens_hsa01100 | 0.98244540 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94049695 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89616006 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89031221 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88901518 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81761286 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80660735 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80564363 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79949765 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79879747 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75990224 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74758467 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73881753 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72719703 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71639169 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69692884 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69310747 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69214913 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66816171 |
| 67 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65550060 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65365278 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63711894 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59455403 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56303406 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53538865 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52014662 |
| 74 | Protein export_Homo sapiens_hsa03060 | 0.51156325 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.46185076 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.45778932 |
| 77 | RNA polymerase_Homo sapiens_hsa03020 | 0.44280040 |
| 78 | DNA replication_Homo sapiens_hsa03030 | 0.43660623 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42901554 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.42469866 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40400937 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38966868 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37885226 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36677177 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35538629 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34694573 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34456835 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.34246743 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33813618 |
| 90 | Mismatch repair_Homo sapiens_hsa03430 | 0.32981303 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29287696 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26512589 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25107457 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.24417208 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.23722578 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.23672805 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.22833466 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.19272735 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19096902 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.16794331 |

